{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:37:20Z","timestamp":1761748640512,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":599,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.acvd.2011.12.001","type":"journal-article","created":{"date-parts":[[2012,2,10]],"date-time":"2012-02-10T08:35:47Z","timestamp":1328862947000},"page":"1-4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["PALLAS: Insights into permanent atrial fibrillation"],"prefix":"10.1016","volume":"105","author":[{"given":"Jean-Marc","family":"Davy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Roubille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Luc","family":"Pasqui\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.acvd.2011.12.001_bib0085","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMoa1109867","article-title":"Dronedarone in high-risk permanent atrial fibrillation","volume":"365","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2011.12.001_bib0010","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/eurheartj\/ehn139","article-title":"Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation","volume":"29","author":"Nieuwlaat","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2011.12.001_bib0090","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/heartjnl-2011-300550","article-title":"Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the realise AF cross-sectional international registry","volume":"98","author":"Steg","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.acvd.2011.12.001_bib0020","doi-asserted-by":"crossref","unstructured":"Davy JM, Herold M, Hoglund C, et al. Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dronedarone for the control of ventricular rate during atrial fibrillation (ERATO) study. Am Heart J 2008; 156:527 e1-9.","DOI":"10.1016\/j.ahj.2008.06.010"},{"key":"10.1016\/j.acvd.2011.12.001_bib0025","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","article-title":"Lenient versus strict rate control in patients with atrial fibrillation","volume":"362","author":"Van Gelder","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2011.12.001_bib0030","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"European Heart Rhythm Association","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2011.12.001_bib0035","first-page":"7","article-title":"Comparing the 2010 North American and European atrial fibrillation guidelines","volume":"27","author":"Gillis","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.acvd.2011.12.001_bib0040","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMoa0803778","article-title":"Effect of dronedarone on cardiovascular events in atrial fibrillation","volume":"360","author":"Hohnloser","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2011.12.001_bib0095","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMe1111997","article-title":"Dronedarone in atrial fibrillation - Jekyll and Hyde?","volume":"365","author":"Nattel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2011.12.001_bib0050","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1056\/NEJMoa0800456","article-title":"Increased mortality after dronedarone therapy for severe heart failure","volume":"358","author":"Kober","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2011.12.001_bib0055","article-title":"Effect of dronedarone in patients with permanent atrial fibrillation during the ATHENA study","volume":"32","author":"Nieuwlaat","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2011.12.001_bib0060","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(10)61259-7","article-title":"Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial","volume":"376","author":"Bohm","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2011.12.001_bib0065","unstructured":"European Medicines Agency. European Medicines Agency recommends restricting use of Multaq. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2011\/09\/news_detail_001344.jsp&mid=WC0b01ac058004d5c1&jsenabled=true 14 December 2011 2011."},{"key":"10.1016\/j.acvd.2011.12.001_bib0070","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM198908103210629","article-title":"Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction","volume":"321","author":"The Cardiac Arrhythmia Suppression Trial (CAST) Investigators","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2011.12.001_bib0075","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.03.034","article-title":"Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation)","volume":"58","author":"Camm","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2011.12.001_bib0080","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMp0902248","article-title":"Dronedarone for atrial fibrillation-an odyssey","volume":"360","author":"Zimetbaum","year":"2009","journal-title":"N Engl J Med"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213611003652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213611003652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:39:27Z","timestamp":1761745167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213611003652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1875213611003652"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2011.12.001","relation":{},"ISSN":["1875-2136"],"issn-type":[{"type":"print","value":"1875-2136"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PALLAS: Insights into permanent atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2011.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}